M. Laridan, consultant at Daxue Consulting, about milk powder industry in China
A sample of the Interview of M. Laridan,
consultant at Daxue
Research, for the NYT, on milk powder industry in China.
Do you think the government's goals are attainable by 2015 and 2018?
According
to the plan, by the end of 2015, 10 large-scale infant formula companies with more
than $ 2 billion annual sales should be formed. The top 10 enterprises in
formula will account for 65% of the market share. By the end of 2018, 3 to 5 of
this company will reach annual sales of $ 5 billion. And the concentration rate
of the market share will be 80%. It creates a feeling that China tends to
create a monopoly in this industry.
However,
the problem is that in China, the majority of Chinese cow are small farmers.
There are no common standard of the feed and dairy breeds of cows. Cows` diary
in different regions may vary a lot. Thus, the quality of milk may be different
especially when a large formula enterprise sets up with milk sourcing base
nationwide. What is more, the plan announced by theMinistry of Industry and
Information Technology mainly focus on the manufacturing process, not the
sourcing process. It cannot ease consumers` mistrust on domestic formula
companies. The key factor of consumers` preference for foreign formula brands the
milk source, which may not be totally copied by domestic companies even these
companies absorb foreign investment and technology.
Whatsoever,
it does not mean that goal cannot be achieved. There`s no doubt that 2 largest
milk companies in China, Mengniu and Yili will make much efforts to follow the
plan. The influence of these two companies makes it easy for them to attract
good source and advanced technology if they will set up a company specialized
in milk powder manufacturing.
Even
though merger and acquisition could be finished in one year, the deadline may
be a bit tense for the establishment of good-quality milk sourcing system of
top 10 companies. Milk companies with good reputation will find business
opportunities because apart from consumers who have preference of foreign
formula, there are still large amount of population who cannot afford foreign
formula. However, the awareness that formula from abroad is of higher hygienic
standard and more nutritious cannot be changed in one year.
Since 2011, the China Food and Drug Administration (the “CFDA”, formerly known as the SFDA) has conducted inspection on foreign drug manufacturing sites for drugs importing into China (the so-called CFDA on-site inspection): http://www.chinadrugconsulting.com/registration-services/cfda-on-site-inspection/cfda-on-site-inspection-2015/
RépondreSupprimer